SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-21-003815
Filing Date
2021-03-11
Accepted
2021-03-11 07:08:09
Documents
14
Period of Report
2021-03-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp147646_8k.htm   iXBRL 8-K 29380
2 EXHIBIT 99.1 dp147646_ex9901.htm EX-99.1 20566
3 GRAPHIC image_001.jpg GRAPHIC 2753
  Complete submission text file 0000950103-21-003815.txt   235731

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bhc-20210311.xsd EX-101.SCH 3196
5 XBRL LABEL FILE bhc-20210311_lab.xml EX-101.LAB 34592
6 XBRL PRESENTATION FILE bhc-20210311_pre.xml EX-101.PRE 22718
7 EXTRACTED XBRL INSTANCE DOCUMENT dp147646_8k_htm.xml XML 3611
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 21731828
SIC: 2834 Pharmaceutical Preparations